Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oxygen-Ozone as Adjuvant Treatment in Early Control of Disease Progression in Patients With COVID-19 Associated With Modulation of the Gut Microbial Flora

NCT04366089 is registered in ClinicalTrials.gov with Roberto Poscia MD, PhD as lead sponsor.

NCT NCT04366089
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04366089 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oxygen-Ozone as Adjuvant Treatment in Early Control of Disease Progression in Patients With COVID-19 Associated With Modulation of the Gut Microbial Flora
Lead sponsor
Roberto Poscia MD, PhD
Phase
Phase 2
Overall status
Unknown status
Start date
March 26, 2020
Completion date
December 31, 2020
Enrollment
152 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus infection, covid, pneumonia, viral, sars-cov 2